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The peripheral benzodiazepine receptor (PBR) is an 18 000 Dalton
transmembrane spanning protein (Joseph Liauzun et al, 1997)
distinct from the central benzodiazepine receptor (Braestrup and
Squires, 1977), that localizes to the outer mitochondrial membrane
where it shares a close physical association with the voltage-
dependent anion channel and adenine nucleotide translocator,
constituents of the permeability transition pore complex (PTPC)
(Anholt et al, 1986; McEnery et al, 1992). This multimeric struc-
ture mediates Ca2+ and oxidative stress-inducible collapse of the
inner mitochondrial membrane potential (∆ Ym) by forming a large
non-specific megachannel with a size cutoff of around 1500
Daltons (Haworth and Hunter, 1979; Petronilli et al, 1994).
Tremendous growth in interest in the physiology of the PTPC has
arisen recently through its involvement in the regulation of both
apoptotic and necrotic cell death, processes which involve early
∆ Ym dissipation (Lemasters et al, 1998). Furthermore, Bcl-2-
related death agonist proteins (e.g. Bax, Bak) and antagonist
proteins (e.g. Bcl-2, Bcl-XL) have been shown to mediate their
reciprocal regulatory actions on cell death directly via an interac-
tion with the PTPC at the outer mitochondrial membrane (Narita et
al, 1998; Shimizu et al, 1999). 
The PBR specifically binds the compound 1-(2-chlorophenyl)-
N-methyl-N-methyl-N-(1-methyl-propyl)-3 isoquinoline-carbox-
amide (PK11195), with nanomolar affinity. This ligand effects a
diverse range of physiological actions including inhibition of cell
proliferation and respiratory control (Hirsch et al, 1989; Camins 
et al, 1995b), effects on mitochondrial protein and cholesterol
translocation (Papadopoulos et al, 1997; Wright and
Reichenbecher, 1999), induction of cell differentiation (Landau et
al, 1998), heat shock protein expression (Camins et al, 1995a), and
facilitation of a diverse range of apoptotic stimuli (Pastorino et al,
1996; Hirsch et al, 1998; Verma et al, 1998). Consequently, a
clearly defined physiological role for the PBR has remained
elusive. PK11195 has been shown to reverse the chemoprotective
effects of Bcl-2; an effect implicating PBR-mediated antagonism
of Bcl-2, and promotion of megachannel formation by the PTPC
(Hirsch et al, 1998). However, evidence from independent groups
has suggested that the anti-proliferative and respiratory inhibiting
effects of PK11195 are receptor-independent (Gorman et al, 1989;
Camins et al, 1995b; Zisterer et al, 1998). Furthermore, the
reported pro-apoptotic actions of PK11195 require concentrations
several orders of magnitude higher than the reported nanomolar
KD for the PBR (Le Fur et al, 1983). In this study, we have set out
to investigate the cytotoxic effects of PK11195. Our findings
suggest an important role for PK11195-induced oxidative stress in
mediating cytotoxicity, and are consistent with a PBR independent
mechanism of action. 
MATERIALS AND METHODS 
Reagents 
5,5¢,6,6¢-tetrachloro-1,1¢,3,3¢-tetraethylbenzimidazolocarbocya-
nine iodide (JC-1), 5-(and-6)-chloromethyl-2¢,7¢-dichlorodihydro-
fluorescein diacetate (CMH2DCFDA), 5-chloromethylfluorescein
diacetate (5-CMFDA), nonyl acridine orange, and 3-3¢-dihexylox-
acarbocyanine iodide (DiOC6(3)) were purchased from Molecular
Probes/Cambridge Bioscience, UK. N-acetylcysteine, VP16, 
ara-C, 5 N,N-dimethylamide (diamide), 1-(2-chlorophenyl)-N-
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(PK11195), carbonylcyanide m-chlorophenylhdrazone (CCCP),
propidium iodide and all cell culture reagents were purchased
from Sigma-Aldrich Ltd, UK. FITC-conjugated mouse anti-
human Bcl-2 monoclonal antibody, and the Dako intrastain fixa-
tion/permeabilization kit were purchased from Dako, UK. 
Cell culture and treatments 
HL60, KG1A, K652 cells stably transfected with the Bcl-2 gene
(K562 B4) or vector only (K562 N2) (kindly provided by Dr DE
Banker and Dr F Applebaum, The Fred Hutchinson Cancer
Research Center, USA), and SUDHL4 lymphoma cell lines, were
maintained in exponential suspension cultures in RPMI 1640
medium supplemented with 10% fetal calf serum, 5 mM gluta-
mine, 100 mgm l –1 streptomycin and 100 U ml–1 penicillin. Cells
were grown in a humidified atmosphere of 5% CO2/95% air at
37˚C. PK11195 was dissolved in ethanol at a stock concentration
of 8.7 mg ml–1, and added to cells at a 75 mM final concentration
for 4 hours; vehicle alone was also used in medium. To test the
effect of an antioxidant on PK11195 activity, cells were treated
with 10 mM N-acetylcysteine for 45 minutes prior to treatment
with PK11195. 
Cells were incubated with VP16, or ara-C at 10 mM final
concentration for 24 hours, or with the thiol crosslinking pro-
oxidant, diamide, at 100 mM concentration for 24 hours. The
protonophore CCCP was used to dissipate ∆ Ym by treating cells at
a concentration of 10 mM for 15 minutes prior to treatment with
PK11195. 
Depletion of mitochondrial DNA 
KG1A cells were depleted of mitochondrial DNA by culturing for
4 months in medium supplemented with ethidium bromide (400
ng ml–1), uridine (5 mgm l –1), and glucose (4.5 mg ml–1). Loss of
mitochondrial DNA was confirmed by 15 cycles of PCR, ampli-
fying a 1023 base pair fragment from the D loop region (upstream
primer 5¢ CAC CAT TAG CAC CCA AAG CT 3¢, reverse primer
5¢ CTG TTA AAA GTG CAT ACC GCC A 3¢). Semi-quantitative
PCR was performed on equal concentrations and serial dilutions of
r0 and r+ DNA, and normalized against nuclear DNA. 
Mitochondrial isolation 
Cells were homogenized mechanically in buffer A (250 mM
sucrose, 10 mM tris, and 1 mM EGTA, pH 7.8 at 4˚C), and the
homogenate centrifuged at 600 g for 10 minutes to remove
membranes and nuclei. This was followed by a second spin at
15 000 g for 5 minutes in buffer B (250 mM sucrose, 10 mM tris)
to obtain a mitochondrial pellet. Analysis at single mitochondrial
resolution was performed by flow cytometry using a FACScan
(Becton Dickinson, UK), running cellquest software; 30 000
events were aquired in listmode and the mitochondrial population
isolated for analysis using a forward versus orthogonal light
scatter gate. 
Measurement of ∆ Ym and mitochondrial mass at single
cell resolution 
Cells were labelled with 5 mgm l –1 of the delocalized lipophilic
cation JC-1 for 10 minutes at 37˚C in the dark, prior to analysis by
flow cytometry. In the presence of a negative membrane potential,
JC-1 forms aggregates which fluoresce in the orange wavelength
to provide a measure of ∆ Ym, whereas the monomeric form fluo-
resces in the green wavelength providing a measure of mitochon-
drial mass. The FL-1 (green) and FL-2 (orange) fluorescence
signals corresponding to the forward and orthogonal scatter gate
circumscribing 10 000 cells were acquired with logarithmic ampli-
fication. To determine the proportion of cells with intact plasma
membrane undergoing ∆ Ym in response to chemotherapy and
diamide, cells were incubated for 20 minutes at 37˚C in the dark
with DiOC6(3) (80 nM), then counter stained for 10 minutes with
propidium iodide (20 mgm l –1). Events with increased PI fluores-
cence (FL3, red) were removed by gating from the DiOC6(3)
histograms (FL1) to eliminate dead cells. 
Measurement of hydrogen peroxide generation and
reduced glutathione 
Cells were loaded for 15 minutes at 37˚C in the dark with
CMH2DCFDA (5 mM) prior to treatment with PK11195, and
washed once prior to analysis by flow cytometry using the FL1
fluorescence detector. Cellular reduced glutathione (GSH) was
estimated by loading cells with 1 mM 5-CMFDA for 45 minutes at
37˚C in the dark. This probe bonds covalently with intracellular
sulfhydryl groups (predominantly GSH) and is then deacetylated
to yield the fluorescent product 5-CMF. Cells were washed once
prior to flow cytometry and 5-CMF fluorescence was detected in
the FL1 wavelength. 
Flow cytometric estimation of Bcl-2 oncoprotein
expression 
Cells (106) were pelleted and fixed for 15 minutes in the dark using
the Dako intrastain solution A (100 ml). The fixed cells were then
simultaneously permeabilized and labelled with 1 mg of FITC
labelled Bcl-2 antibody for 15 minutes in Dako intrastain solution
B. Cells were washed, and analysed using the FL1 detector. 
Statistics 
Unpaired Student’s t-test was used to evaluate the statistical differ-
ences between experiments repeated in triplicate. P values shown
are two-sided. 
RESULTS 
PK11195 mediates anti-oxidant inhibitable ∆ Ym collapse
in HL60 cells but not SUDHL4 cells 
The effect of PK11195 on ∆ Ym was investigated in a range of cell
lines using the mitochondrial potentiometric probe JC-1 (Reers et
al, 1995). HL60 leukaemia cells treated with PK11195 exhibited a
reduction in JC-1 aggregate fluorescence consistent with a
collapse in ∆ Ym (Figures 1A and 1B). Pre-treatment of HL60 cells
with 10 mM N-acetylcysteine, a sulfhydryl donor and antioxidant,
prevented the collapse in ∆ Ym mediated by PK11195 (Figure 1C).
PK11195 failed to dissipate ∆ Ym in the Bcl-2 hyperexpressing
SUDHL4 lymphoma cell line, but rather, consistently mediated 
an increase in JC-1 green fluorescence resulting in the appearance
of a second, discrete population of cells with decreased JC-1
orange:JC-1 green fluorescence ratio (Figures 1D and 1E).
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associated with an increase in the intensity of mitochondrial cardi-
olipin labelling by nonyl-acridine orange. The appearance of the
PK11195-induced SUDHL4 cell population exhibiting an increase
in JC-1 green fluorescence was inhibited by 10 mM N-acetylcys-
teine (Figure 1F). 
The differential sensitivity of HL60 versus SUDHL4 cells to
PK11195 induced ∆ Ym collapse was also reflected in the differen-
tial tolerance of these cell lines to mitochondrial depolarization
induced by cytotoxic chemotherapy and the pro-oxidant diamide,
as measured by the potentiometric probe DiOC6(3). Treatment
with 10 mM Ara-C or 10 mM VP16 mediated ∆ Ym collapse in a
greater fraction of HL60 cells compared with SUDHL4 cells
(Figure 2A); this order of differential sensitivity was also observed
after treatment with 100 mM diamide (Figure 2A). 
PK11195 induces generation of reactive oxygen species
independently of a functional respiratory chain 
To investigate the differential effects of PK11195 on HL60 and
SUDHL4 cells, the production of reactive oxygen species (ROS)
was measured at single cell resolution using the fluorescent probe
CMH2DCFDA which covalently bonds to intracellular sulfhydryl
groups during loading, and is de-acetylated by hydrogen peroxide
to generate the fluorescent product CMH2DCF. Following treat-
ment with PK11195, an increase in green fluorescence of greater
than one log, was observed in both cell lines (Figure 2B and 2C). 
To investigate the role of the respiratory chain in mediating the
production of ROS, KG1A leukaemia cells were depleted of their
mitochondrial DNA (KG1A r0) by long-term culture in the pres-
ence of ethidium bromide (Figure 2D). Both r+ and r0 KG1A cells
responded to treatment with PK11195 by increasing CMH2DCF
fluorescence (Figures 2E and 2F). 
Bcl-2 expression does not prevent PK11195-induced
ROS generation 
To determine the effect of Bcl-2 on PK11195-induced production
of ROS, K562 myeloid leukaemia cells transfected with the Bcl-2
gene (Figure 3A) were treated with PK11195 after loading with
CMH2DCFDA. Bcl-2 expression, shown by immunofluorescence
to be predominantly mitochondrial, (Dr Deborah Banker, personal
communication), did not affect the PK11195-induced increase in
CMH2DCF fluorescence, which was equivalent in K562 N2 and
K562 B4 cell lines (Figures 3B and 3C). 
Mitochondrial toxicity of PK11195 involves generation of reactive oxygen species 1399
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Figure 1 Differential effects of PK11195 on ∆ Ym in HL60 versus SUDHL4 cells. (A) HL60 cells stained with the potentiometric probe JC-1 exhibit orange
aggregate fluorescence reflecting mitochondrial energization (y-axis), and green monomer fluorescence reflecting mitochondrial mass (x-axis). Control cells are
localized to the upper left quadrant. (B) Treatment with PK11195 for 4 hours reduced JC-1 orange fluorescence, dissipating ∆ Ym, and leading to an increased
frequency of events in the lower right quadrant. (C) Pre-treatment with 10 mM N-acetylcysteine prevented PK11195 induced ∆ Ym collapse. (D) SUDHL4 cells
stained with JC-1 (control) localize to the upper left quandrant. (E) Treatment of SUDHL4 cells with PK11195 resulted in the emergence of a population with high
JC-1 green fluorescence localizing to the upper right quadrant. (F) Pre-treatment of SUDHL4 cells with 10 mM N-acetylcysteine prevented the PK11195
mediated increase in JC-1 green fluorescence The differential effects of the pro-oxidant diamide on HL60 and
SUDHL4 cells, and the reversibility of PK11195 induced ∆ Ym
collapse in HL60 cells by antioxidant, suggested that the under-
lying sensitivity of these contrasting cell lines may result from
intrinsic differences in their oxidant stress buffering capacities.
Using the sulfhydryl-reactive fluorescent probe 5-CMFDA to esti-
mate reduced glutathione (GSH) at single cell resolution, Bcl-2
transfection was found not to produce a change in 5-CMF fluores-
cence (Figure 3D). However, SUDHL4 cells exhibited greater 
5-CMF fluorescence compared with HL60 cells (Figure 3E). 
Mitochondrial toxicity mediated by PK11195 requires
mitochondrial energization 
To examine the pro-oxidant effects of PK11195 at the sub-cellular
level, mitochondria were isolated from HL60 and SUDHL4 cells
after treatment with PK11195. HL60 mitochondria consistently
increased the median of their forward light scatter distribution by
approximately one log compared with control, consistent with an
increase in mitochondrial size occurring at a time coincident with
ROS generation (Figure 3F). However, an increase in forward
scatter was not observed in SUDHL4 mitochondria after 4 hours
of incubation (not shown). 
Production of ROS by PK11195 was found to be restricted to
cells with normal (non-apoptotic) morphology, reflected in the
forward and side light scatter distributions (FSC and SSC respec-
tively). Cells undergoing apoptosis exhibit an increase in SSC
(reflecting an increased granularity), and a reduction in FSC
(reflecting a reduction in cell size); we have previously observed
an association with ∆ Ym collapse in this low FSC/high SSC popu-
lation (Fennell and Cotter, 2000). HL60 cells treated with
PK11195 exhibited an increase in apoptotic (low FSC/high SSC)
frequency associated with a reduction in membrane potential
(Figure 4A), that was not seen in SUDHL4 cells. When the apop-
totic and normal cells were gated (using the regions denoted R1
and R2 respectively), ROS production was only observed in the
morphologically normal cells (Figure 4B). This observation
suggested a requirement for mitochondrial energization in the
generation of ROS by PK11195. To test this hypothesis, HL60
cells were treated with the protonophore CCCP to collapse ∆ Ym
prior to treatment with PK11195 (Figure 4C). In the presence of
CCCP, PK11195 failed to increase CMH2DCF fluorescence
compared with control, in contrast to cells treated with PK11195 in
the absence of the protonophore (Figures 4D and 4E). 
DISCUSSION 
In this study, we have investigated the cytotoxicity of the PBR
ligand PK11195 in a range of haemopoetic cell lines. The relative
susceptibility of HL60 cells versus SUDHL4 cells to mitochondrial
1400 DA Fennell et al 
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Figure 2 PK11195 mediates ROS production in HL60, SUDHL4 cells and r0 cells. (A) HL60 cells exhibited relative sensitivity to ∆ Ym collapse measured by
DiOC6(3), compared to SUDHL4 cells, induced by the cytotoxic chemotherapeutic drugs ara-c and VP16, as well as the pro-oxidant diamide. (B) PK11195
induced ROS production in SUDHL4 cells with a one log fold increase in CMH2DCF fluorescence. (C) PK11195 induced ROS generation was associated with a
two log fold increase in CMH2DCF fluorescence. (D) Loss of mitochondrial DNA in r0 cells demonstrated by PCR amplification of a 1023 basepair amplicon from
the D loop region. (E) KG1A r+ cells responded to PK11195 by generating ROS. F. PK11195 generated ROS in KG1A r0 cells depolarization induced by PK11195, chemotherapeutic drugs and
the pro-oxidant diamide suggests a role for intrinsic anti-oxidant
defences in modulating the toxicity of PK11195. This was
supported by the observation that exogenous antioxidant treatment
protects HL60 cells from PK11195 induced mitochondrial toxicity,
consistent with an involvement of ROS in mediating ∆ Ym
collapse. The ability of PK11195 to induce ROS generation in the
presence of sustained ∆ Ym in SUDHL4 cells implies that ∆ Ym
collapse is not a prerequisite for ROS generation, in contrast to the
paradigm described by Zamzami et al in relation to several other
apoptosis-inducing toxins (Zamzami et al, 1995). 
SUDHL4 cells exhibited a relatively higher GSH concentration
compared with HL60 cells and could account for the greater inten-
sity of PK11195-induced CMH2DCF fluorescence in HL60 cells
(approximately one log fold). Bcl-2 transfection was not found to
attenuate the generation of ROS in K562 cells, nor modulate
cellular GSH content; however, Bcl-2 could conceivably antago-
nize ROS-induced permeability transition via its well described
stabilizing effect on the permeability transition pore complex, the
gating of which is regulated by the redox state of critical vicinal
thiols (Costantini et al, 1996, 2000; Marzo et al, 1998). This would
be consistent with our finding that PK11195 can induce mitochon-
drial swelling in HL60 mitochondria, but not in SUDHL4 mito-
chondria which hyperexpress Bcl-2 due to t(14;18). 
The increase in JC-1 monomer fluorescence that we observed in
PK11195 treated SUDHL4 cells has been previously reported to
occur as an early event during some forms of apoptosis, and has
been shown to reflect mitochondrial proliferation using corrobora-
tive transmission electron microscopy (TEM) (Mancini et al, 1997,
1998). The observed increase in cardiolipin labelling of SUDHL4
cells by nonyl-acridine orange has also been reported by Miccoli 
et al to occur in PK11195-treated human glioma cells, consistent
with an increase in mitochondrial mass (Miccoli et al, 1999).
Becker’s group reported PK11195-induced mitochondrial prolifer-
ation using TEM in rat C6 glioma cells and pituitary GH3 cells
(Shiraishi et al, 1991; Black et al, 1994), however, the basis for this
proliferation was not investigated. Transcription of nuclear mito-
chondrial biogenesis genes is induced by oxidative stress (Miranda
et al, 1999), consistent with observations by us and by Camins et al
(Camins et al, 1995a) that PK11195 induces ROS, and may there-
fore underlie the antioxidant reversible increase in JC-1 green and
NAO fluorescence. 
PK11195 facilitated mitochondrial permeability transition
induced by a diversity of apoptosis inducers has been previously
Mitochondrial toxicity of PK11195 involves generation of reactive oxygen species 1401
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Figure 3 ROS production by PK11195 is Bcl-2 resistant and is temporally associated with an increase in mitochondrial size. (A) K562 B4 cells transfected with
the Bcl-2 gene exhibited increased Bcl-2 oncoprotein expression compared with K562 N2 cells, as measured by immunofluorescence. (B) K562 N2 responded
to PK11195 treatment by increasing CMH2DCF fluorescence. (C) Bcl-2 transfection did not prevent PK11195 induced ROS generation in K562 B4 cells. (D)
Reduced cellular glutathione content measured at single cell resolution by CMFDA fluorescence was not affected by Bcl-2 transfection in K562 B4 versus K562
N2 cells. (E) SUDHL4 cells exhibited a greater reduced glutathione (GSH) content compared with HL60 cells. (F) HL60 mitochondria isolated from PK11195-
treated cells exhibited an increase in the distribution of forward scatter reflecting a general increase in individual size reported (Pastorino et al, 1994, 1996; Hirsch et al, 1998), as well
as direct induction of ∆ Ym dissipation in thymocytes (Tanimoto
et al, 1999). The requirement for micromolar concentrations of
PK11195 to achieve the effects described in this study suggests a
mechanism of toxicity that is independent of the PBR, since the
equilibrium-binding constant is only 1 nM (Le Fur et al, 1983).
Carayon et al showed that PBR transfection could protect Jurkat
leukaemia cells from ROS induced cytotoxicity (Carayon et al,
1996). However, we have observed that SUDHL4 and BV173
cells exhibit comparable PBR expression, (measured using 7-
nitro-2,1,3-benzoxadiazol-4-y1 derivative of 2-phenylindole-3-
acetamide (NBD FGIN-1-27 analogue), a fluorescent PBR probe
(Kozikowski et al, 1997)), yet exhibit differential tolerance to the
effects of PK11195 on ∆ Ym; furthermore, Jurkat T cells which lack
demonstrable NBD FGIN-1-27 binding, dramatically produce
ROS in response to PK11195 (unpublished data). The origin of
PK11195 induced ROS is unknown. CMH2DCFDA is oxidized to
CMH2DCF by H2O2, which is generated intracellularly by dismu-
tation of superoxide catalysed by manganese superoxide dismu-
tase (MnSOD). The principal mitochondrial defence against H2O2
is the glutathione redox cycle system which converts H2O2 to H2O
at the expense of GSH oxidation to its disulfide, GSSG, by the
action of glutathione peroxidase. The relatively lower 5-CMF
fluorescence of HL60 cells, is consistent with a lower total cellular
GSH level, which could increase susceptibility to oxidation of the
mitochondrial GSH pool by PK11195 compared with SUDHL4
cells. Disruption of mitochondrial H2O2 defences allows the gener-
ation of hydroxyl radical via contact with transition metal ions
(Cu+ or Fe2+) with the potential to trigger permeability transition.
The chloromethyl function of CMH2DCFDA is thiol reactive,
however, GSH is present in the millimolar range (some 3 orders of
magnitude greater than the concentration of CMH2DCFDA),
arguing on stoichiometric grounds, against an artefactual pertuba-
tion in intracellular GSH levels as a basis for PK11195-mediated
ROS. 
Generation of H2O2 in KG1A r0 cells suggests that a functional
respiratory chain is not required for PK11195-induced ROS.
However, we have shown in this study that ∆ Ym (maintained in r0
cells by reverse proton flux through complex V) is a pre-requisite
for ROS production. PK11195 may therefore require ∆ Ym-
dependent entry into the mitochondrial matrix in a manner resem-
bling the isoquinoline derivative N-methyl 4-phenyl pyridine,
which occurs after protonation of 1 methyl 4 phenyl 1,2,3,6
tetrahydropyridine (MPTP) (Ramsay et al, 1986); experiments to
test this electrophoretic import hypothesis are currently under
investigation. The reported Bcl-2 reversing efficacy of PK11195
suggests that this compound may possess useful apoptosis-
sensitizing efficacy, with potential application for the therapy of
apoptosis-resistant malignancies (Hirsch et al, 1998). Further
investigations to unravel underlying mechanisms of its pro-apop-
1402 DA Fennell et al 
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Figure 4 Requirement for mitochondrial energisation in the production of ROS by PK11195 in HL60 cells. (A) Distribution of forward and side light scatter of
PK11195 treated HL60 cells with regional gating of apoptotic (R1) and normal (R2) subpopulations. (B) Histogram showing the relative increase in CMH2DCF
fluorescence associated with PK11195 treatment in HL60 cells from gates R1 and R2 morphology. (C) CCCP (10 mM) induced reduction in ∆ Ym in HL60 cells
measured as a lower DiOC6(3) fluorescence. (D). CMH2DCF fluorescence in HL60 cells treated with 10 mM CCCP only (control) (E). PK11195 failed to increase
CMH2DCF fluorescence in HL60 cells treated with 10 mM CCCP 
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stotic activity should help to separate PBR versus PBR ligand-
dependent processes, and in so doing, clarify the biological role of
this elusive receptor. 
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